The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
December 8th 2024
A propensity score-matched study from ASH 2024 suggests GLP-1 RA use reduced VTE risk in type 2 diabetes.
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
Smoking Cessation Therapy Does Not Interfere with Simultaneous Stimulant Addiction Treatment
A study published in The Journal of Clinical Psychiatry concludes that adults dependent on cocaine and/or methamphetamine who undergo stimulant addiction treatment does not detract from simultaneous smoking cessation therapy, and can even increase likelihood of quitting.
Mediterranean Diet as a Primary Prevention of Cardiovascular Disease
December 1st 2013Compared to a low-fat diet, adherence to a Mediterranean diet has significant benefit in the primary prevention of cardiovascular disease among patients aged 55-80 years old at high baseline cardiovascular risk without cardiovascular disease.
Nighttime Intensivists: A Question of Whether More Is Better
December 1st 2013A number of studies have shown that either a "high-intensity" intensive care unit (ICU), in which all ICU patients are cared for by an intensivist, or one in which an intensivist team consult is mandatory, improves outcomes in the ICU. But does the presence of an intensivist in the ICU around the clock improve outcomes?
FDA Reduces Restrictions on Diabetes Medication Rosiglitazone
November 26th 2013Following an extended review of safety data that showed no elevated risk of heart attack or death in patients taking rosiglitazone, the FDA announced it is lifting certain restrictions on the prescribing and dispensing of the drug.
Study Looks at Effect of Vitamin D Deficiency on Treatment for Hypertension
November 22nd 2013With nearly one-third of US adults suffering from vitamin D deficiency, and studies showing a strong association between vitamin D deficiency and hypertension risk, supplementation with vitamin D may increase the effectiveness of hypertension treatments.
Aspirin at Bedtime vs. Aspirin in the Morning: Which Produces Greater Cardiovascular Benefits?
November 22nd 2013Although there appears to be no difference in blood pressure reduction in patients who take aspirin at bedtime compared to those who take it when they awake in the morning, bedtime aspirin may be associated with reduced morning platelet reactivity.
Bioengineered Blood Vessel Offers Potential Improvements for Dialysis Patients
November 21st 2013Initial results from human clinical trials involving the use of bioengineered blood vessels could point the way to cost-effective alternative therapies for hemodialysis patients with end-stage renal disease.